2-propanol has been researched along with travoprost in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrew, R; Bergamini, MV; Davis, AA; Dickerson, J; Landry, T; Mallick, S; Netland, PA; Robertson, SM; Silver, L; Sullivan, EK; Weiner, A | 1 |
| Albert, DM; Drago, F; Hu, DN; Stjernschantz, JW; Wistrand, PJ | 1 |
| Huang, P; Liu, W; Wu, L; Zhong, Z | 1 |
| Gao, YX; Huang, P; Li, B; Wang, ZX; Wu, LL | 1 |
| Aung, T; Baskaran, M; Chew, PT; Goh, D; Ho, CL; Htoon, HM; Narayanaswamy, A; Nongpiur, ME; Perera, SA; Su, DH; Tun, TA; Wong, TT | 1 |
1 review(s) available for 2-propanol and travoprost
| Article | Year |
|---|---|
Mechanism and clinical significance of prostaglandin-induced iris pigmentation.
Topics: Amides; Animals; Antihypertensive Agents; Bimatoprost; Cloprostenol; Dinoprost; Eye Color; Gene Expression Regulation; Humans; Iris; Iris Diseases; Latanoprost; Lipids; Melanocytes; Monophenol Monooxygenase; Pigmentation Disorders; Prostaglandins F, Synthetic; Receptors, Prostaglandin; Travoprost; Up-Regulation | 2002 |
4 trial(s) available for 2-propanol and travoprost
| Article | Year |
|---|---|
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cloprostenol; Double-Blind Method; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pigmentation Disorders; Prodrugs; Prostaglandins F, Synthetic; Safety; Timolol; Travoprost; Treatment Outcome | 2001 |
Increased iridial pigmentation in Chinese eyes after use of travoprost 0.004%.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; China; Cloprostenol; Dose-Response Relationship, Drug; Double-Blind Method; Eye Color; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Incidence; Iris; Iris Diseases; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prognosis; Prospective Studies; Travoprost; Young Adult | 2009 |
A 12-week, double-masked, parallel-group study of the safety and efficacy of travoprost 0.004% compared with pilocarpine 1% in Chinese patients with primary angle-closure and primary angle-closure glaucoma.
Topics: Aged; Anterior Eye Segment; Antihypertensive Agents; Asian People; China; Cloprostenol; Double-Blind Method; Female; Glaucoma, Angle-Closure; Gonioscopy; Humans; Intraocular Pressure; Iridectomy; Iris; Laser Therapy; Male; Ophthalmic Solutions; Pilocarpine; Tonometry, Ocular; Travoprost; Treatment Outcome | 2011 |
Argon Laser Peripheral Iridoplasty for Primary Angle-Closure Glaucoma: A Randomized Controlled Trial.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Iridectomy; Iris; Lasers, Excimer; Male; Middle Aged; Reoperation; Tertiary Care Centers; Tonometry, Ocular; Travoprost; Treatment Outcome | 2016 |